CTLA4 and breast cancer: Analysis of PD-L1 (CD274) and CTLA4 transcript expression based on receptor subtype in primary BC demonstrated an increased expression in the TNBC cases but did not reach statistical significance (P = 0.1772 and P = 0.0722, respectively, Figure 3B) due to the low number of TNBC cases.